Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Sekur Private Data Signs Distribution Agreement In Africa (click to learn more) Pinnacle Discovers Silver-Lead-Zinc Mineralization Following up on LiDAR Survey at El Potrero (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Kuros Bioscience Ltd (PK) CSBTF

Healthcare Medical Devices
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface... see more

Current News (PINL:CSBTF)

Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division

ACCESS Newswire January 7, 2025

Kuros Biosciences Expands into Extremities Markets

ACCESS Newswire November 19, 2024

Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024

ACCESS Newswire October 10, 2024

Kuros Biosciences Reports First Half of 2024 Results

ACCESS Newswire August 8, 2024

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft

ACCESS Newswire June 25, 2024

Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales

ACCESS Newswire April 24, 2024

Annual General Meeting of Kuros Biosciences Approves All Resolutions

ACCESS Newswire April 17, 2024

Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023

ACCESS Newswire March 13, 2024

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update

ACCESS Newswire March 8, 2024
View More News ››

Opinion & Analysis (PINL:CSBTF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:CSBTF)

Be the first to post on this bullboard.

Birchtech Corp.

Birchtech Corp.

Birchtech Corp., an environmental services and technology company, engages in developing and delivering solutions to the ...
View More »

Podcasts